Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03390296
What this trial is testing

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 50
Not applicableStudy completedNCT04328662
What this trial is testing

Ninlaro in Real World Clinical Practice in China

Who this might be right for
Multiple MyelomaNeoplasms, Plasma Cell
Takeda 482
Testing effectiveness (Phase 2)Active Not RecruitingNCT04497961
What this trial is testing

Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 95
Early research (Phase 1)UnknownNCT05643417
What this trial is testing

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Who this might be right for
Metastatic Liver Cancer
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT00006890
What this trial is testing

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 67
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Early research (Phase 1)Study completedNCT01713582
What this trial is testing

A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Testing effectiveness (Phase 2)Study completedNCT03439280
What this trial is testing

Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Who this might be right for
Relapsed/RefractoryMultiple Myeloma
Millennium Pharmaceuticals, Inc. 50
Not applicableStudy completedNCT02627261
What this trial is testing

Multiple Myeloma Minimal Residual Disease

Who this might be right for
Multiple Myeloma
Hospices Civils de Lyon 48
Not applicableStudy completedNCT00629460
What this trial is testing

A Pilot Study of PET-CT in the Assessment of Pulmonary Nodules in Children With Malignant Solid Tumors

Who this might be right for
Pulmonary Nodules
St. Jude Children's Research Hospital 27
Not applicableLooking for participantsNCT06312124
What this trial is testing

Opportunistic Salpingectomy to Prevent Ovarian Cancer

Who this might be right for
Surgery
Memorial Sloan Kettering Cancer Center 266
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Testing effectiveness (Phase 2)Study completedNCT02221479
What this trial is testing

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 14
Not applicableStudy completedNCT04789980
What this trial is testing

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Boryung Pharmaceutical Co., Ltd 799
Large-scale testing (Phase 3)Study completedNCT00612742
What this trial is testing

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

Who this might be right for
Hypoactive Sexual Desire Disorder
BioSante Pharmaceuticals 3,656
Testing effectiveness (Phase 2)UnknownNCT00434369
What this trial is testing

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

Who this might be right for
Breast Cancer
Mast Therapeutics, Inc. 31
Early research (Phase 1)Active Not RecruitingNCT05552469
What this trial is testing

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Who this might be right for
Myeloid Diseases
Novartis Pharmaceuticals 71
Early research (Phase 1)Not Yet RecruitingNCT06699576
What this trial is testing

ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.

Who this might be right for
OsteosarcomaSoft Tissue Sarcoma (STS)
Hansoh BioMedical R&D Company 448
Testing effectiveness (Phase 2)Looking for participantsNCT05236582
What this trial is testing

Herombopag for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Next Page